Mitochondrial dysfunction contributes to oncogene-induced senescence.
about
Feedback between p21 and reactive oxygen production is necessary for cell senescenceCellular Senescence as the Causal Nexus of AgingAxis of ageing: telomeres, p53 and mitochondriaLive imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammationTherapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New TricksInterplay between oxidant species and energy metabolismNovel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapyGlucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterationsProtein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation.Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cellsCellular senescence and protein degradation: breaking down cancermTOR Signaling from Cellular Senescence to Organismal AgingInsulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence.Impaired OXPHOS complex III in breast cancerRejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.iPSCs as a major opportunity to understand and cure age-related diseases.Mitochondria are required for pro-ageing features of the senescent phenotype.The role of TGF-β1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells.The essence of senescence.The aging signature: a hallmark of induced pluripotent stem cells?The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis.Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.Investigation of cyanine dyes for in vivo optical imaging of altered mitochondrial membrane potential in tumors.Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence.Mitochondrial effectors of cellular senescence: beyond the free radical theory of agingReactive oxygen species production and mitochondrial dysfunction in white blood cells are not valid biomarkers of ageing in the very oldMitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin.Oncogene-induced senescence results in marked metabolic and bioenergetic alterationsHuman Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by p53 during senescence.EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancerDifferential Proteomic Analysis of Human Placenta-Derived Mesenchymal Stem Cells Cultured on Normal Tissue Culture Surface and Hyaluronan-Coated Surface.Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.Pleiotropic actions of estrogen: a mitochondrial matter.Matched and mismatched metabolic fuels in lymphocyte function.AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival.MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradationArginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability
P2860
Q24299631-669FFD68-3124-449D-9837-B5F4497DE47FQ26767454-BC58C61A-9F43-4CA3-BEB1-9EFA4F0103E7Q26865873-97CCE5D8-7EE2-4D82-BC58-42BF18FD94EBQ27322639-ED96F318-9086-40AC-839C-744645FC71BAQ28069996-EC6A643B-1D83-45BD-BE50-6CCF987DA878Q28383905-655F1038-1D11-45C4-BAB8-EA95C33D73ECQ28483560-11654729-3873-4FF6-B13E-9576EE89324BQ28582048-5E597AF2-C43B-40F1-9EC1-D5A4E9011A3AQ33694680-DCAD6853-3B5B-4B0E-89E4-32FE11B8905CQ33812688-E016B54A-D5A7-4366-BA96-97E002DE6635Q33953067-B0A77E2F-009D-4E14-8D3C-0B82BC5EA86BQ33962054-8868E5AB-155C-4281-B184-C18039646220Q33986884-8BD705E2-086C-4A6A-998D-E1A8E9E14E3EQ34013764-1B27714B-E61B-486B-AE1B-4533245983C9Q34029292-8090D2A4-E805-487D-ACD1-9A51FD2BD82FQ34044029-8B1418DC-2F3D-4315-B7E6-CC76EC93C127Q34046100-A484325F-8B32-4409-A282-FC578F181EE4Q34051982-02BA6392-BFF6-460C-905C-2411EB8C68E4Q34288983-F1FA9287-9A00-427F-94EE-A2E096BAC31CQ34386434-C840D081-E964-42BC-BA55-8C572F798BBAQ34601400-B3806A0A-3020-47F2-8B0F-D7AE5DD081D9Q34676703-3AC741B3-240A-4FD0-898F-5BA0A638C580Q34963818-989E1A73-E8B3-4DAB-BC9C-50F45E36D21DQ35000393-1FE81E5A-41E7-42C4-A171-7B2A5F5D95A1Q35007125-DD60B83C-5D81-4327-A1C2-26645293B15DQ35027745-64048D24-3280-4885-8C25-3222A394FA48Q35116534-C72970C7-A3C6-4FE9-BEFC-B81239EAA73FQ35799801-C4516264-9EB3-4970-A43E-6CFA7783CC3EQ35954897-DD6C37F9-9BFC-40C0-AE8E-D698E4B268ADQ36129977-338166A1-A73A-4125-8D59-C0FDA5E52EE8Q36382580-18C171D1-05EA-497F-A000-932B5BD74265Q36394649-D1603B09-1430-4B76-97DE-12DA10313A0FQ36453964-DA14B438-CD99-4219-AF60-0CDED36F859DQ36568015-9E83E492-B35F-4AF3-9C02-E30118D94047Q36599931-F524B47D-49AA-4EA6-9C42-1AC68B38148BQ36640334-091657C3-5525-4085-AB52-4CB97E1DC719Q36800650-0FDB7F1A-6EA7-44C1-AF4F-6881CC45613DQ36802020-24662150-70B9-466F-8057-3B9928316D91Q36832181-44CBEF37-3A5C-4E64-97E7-58FF464C18E9Q37310506-72503F83-DEE5-4432-B707-841F14950A83
P2860
Mitochondrial dysfunction contributes to oncogene-induced senescence.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@en
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@nl
type
label
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@en
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@nl
prefLabel
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@en
Mitochondrial dysfunction contributes to oncogene-induced senescence.
@nl
P2093
P2860
P356
P1476
Mitochondrial dysfunction contributes to oncogene-induced senescence
@en
P2093
Antoine Roux
Olga Moiseeva
Véronique Bourdeau
P2860
P304
P356
10.1128/MCB.01868-08
P407
P577
2009-06-15T00:00:00Z